Susan S. Jacobs

1.7k total citations
18 papers, 768 citations indexed

About

Susan S. Jacobs is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Infectious Diseases. According to data from OpenAlex, Susan S. Jacobs has authored 18 papers receiving a total of 768 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 6 papers in Epidemiology and 2 papers in Infectious Diseases. Recurrent topics in Susan S. Jacobs's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers) and Respiratory Support and Mechanisms (5 papers). Susan S. Jacobs is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers) and Respiratory Support and Mechanisms (5 papers). Susan S. Jacobs collaborates with scholars based in United States, Spain and Australia. Susan S. Jacobs's co-authors include Stephen J. Ruoss, Peter N. Kao, Glenn D. Rosen, Ke Wei, Wenteh Chang, Tomasz M. Ziedalski, Noreen Henig, S Janson-Bjerklie, Hannah Peavy and Kevin McCarthy and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Susan S. Jacobs

16 papers receiving 751 citations

Peers

Susan S. Jacobs
Susan S. Jacobs
Citations per year, relative to Susan S. Jacobs Susan S. Jacobs (= 1×) peers Kazumasa Yasuda

Countries citing papers authored by Susan S. Jacobs

Since Specialization
Citations

This map shows the geographic impact of Susan S. Jacobs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan S. Jacobs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan S. Jacobs more than expected).

Fields of papers citing papers by Susan S. Jacobs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan S. Jacobs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan S. Jacobs. The network helps show where Susan S. Jacobs may publish in the future.

Co-authorship network of co-authors of Susan S. Jacobs

This figure shows the co-authorship network connecting the top 25 collaborators of Susan S. Jacobs. A scholar is included among the top collaborators of Susan S. Jacobs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan S. Jacobs. Susan S. Jacobs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Jacobs, Susan S., et al.. (2025). A Person-Centered Approach to Supplemental Oxygen Therapy in the Outpatient Setting. JAMA Internal Medicine. 185(6). 720–720.
2.
Sharifi, Husham, et al.. (2024). Variables associated with antibiotic treatment tolerance in patients with Mycobacterium avium complex pulmonary disease. Respiratory Research. 25(1). 123–123. 2 indexed citations
3.
Mooney, Joshua J., Susan S. Jacobs, Éric Lefebvre, et al.. (2024). Bexotegrast Shows Dose-Dependent Integrin αvβ6 Receptor Occupancy in Lungs of Participants with Idiopathic Pulmonary Fibrosis: A Phase 2, Open-Label Clinical Trial. Annals of the American Thoracic Society. 22(3). 350–358. 8 indexed citations
4.
Jacobs, Susan S., et al.. (2023). Is it time to include oxygen needs as an endpoint in clinical trials in patients with fibrosing interstitial lung disease? If so, how?. BMJ Open Respiratory Research. 10(1). e001546–e001546. 1 indexed citations
5.
Khor, Yet H., Katherine A. Dudley, Derrick Herman, et al.. (2021). Summary for Clinicians: Clinical Practice Guideline on Home Oxygen Therapy for Adults with Chronic Lung Disease. Annals of the American Thoracic Society. 18(9). 1444–1449. 6 indexed citations
6.
Chung, Melody P., H. Henry Guo, Shufeng Li, et al.. (2020). Rituximab Versus Mycophenolate in the Treatment of Recalcitrant Connective Tissue Disease–Associated Interstitial Lung Disease. ACR Open Rheumatology. 3(1). 3–7. 6 indexed citations
7.
Jacobs, Susan S.. (2019). Clinician Strategies to Improve the Care of Patients Using Supplemental Oxygen. CHEST Journal. 156(3). 619–628. 6 indexed citations
8.
Lindell, Kathleen O., Eileen G. Collins, Chris Garvey, et al.. (2018). Equipment, access and worry about running short of oxygen: Key concerns in the ATS patient supplemental oxygen survey. Heart & Lung. 48(3). 245–249. 12 indexed citations
9.
Jacobs, Susan S., Kathleen O. Lindell, Eileen G. Collins, et al.. (2017). Patient Perceptions of the Adequacy of Supplemental Oxygen Therapy. Results of the American Thoracic Society Nursing Assembly Oxygen Working Group Survey. Annals of the American Thoracic Society. 15(1). 24–32. 41 indexed citations
10.
Chang, Wenteh, Ke Wei, Lawrence Ho, et al.. (2014). A Critical Role for the mTORC2 Pathway in Lung Fibrosis. PLoS ONE. 9(8). e106155–e106155. 48 indexed citations
11.
Bennett, Mihoko V., et al.. (2011). An Analysis of Connective Tissue Disease-associated Interstitial Lung Disease at a US Tertiary Care Center: Better Survival in Patients with Systemic Sclerosis. The Journal of Rheumatology. 38(4). 693–701. 24 indexed citations
12.
Chang, Wenteh, Ke Wei, Susan S. Jacobs, et al.. (2010). SPARC Suppresses Apoptosis of Idiopathic Pulmonary Fibrosis Fibroblasts through Constitutive Activation of β-Catenin. Journal of Biological Chemistry. 285(11). 8196–8206. 89 indexed citations
13.
Kao, Peter N., et al.. (2007). Aerosolized amikacin for treatment of pulmonary Mycobacterium aviuminfections: an observational case series. BMC Pulmonary Medicine. 7(1). 2–2. 64 indexed citations
14.
Ziedalski, Tomasz M., Peter N. Kao, Noreen Henig, Susan S. Jacobs, & Stephen J. Ruoss. (2006). Prospective Analysis of Cystic Fibrosis Transmembrane Regulator Mutations in Adults With Bronchiectasis or Pulmonary Nontuberculous Mycobacterial Infection. CHEST Journal. 130(4). 995–1002. 90 indexed citations
15.
Ryu, Jay H., Joel Moss, Gerald J. Beck, et al.. (2005). The NHLBI Lymphangioleiomyomatosis Registry. American Journal of Respiratory and Critical Care Medicine. 173(1). 105–111. 305 indexed citations
16.
Lindell, Kathleen O. & Susan S. Jacobs. (2003). Idiopathic Pulmonary Fibrosis. AJN American Journal of Nursing. 103(4). 32–42. 7 indexed citations
17.
Banks, Evelyn R., C. Darrell Jennings, Susan S. Jacobs, & Diane D. Davey. (1994). Comparative assessment of DNA analysis in effusions by lmage analysis and flow cytometry. Diagnostic Cytopathology. 10(1). 62–66. 10 indexed citations
18.
Janson-Bjerklie, S, et al.. (1984). The sensation of dyspnea: a review.. PubMed. 13(4). 436–47. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026